文献速递牙体牙髓病

生物陶瓷iRoot BP Plus直接盖髓治疗症状性不可逆性牙髓炎的长期生存与结局

Long-term Survival and Outcomes of Direct Pulp Capping with Bioceramic iRoot BP Plus in Symptomatic Irreversible Pulpitis.
PubMed 文献 · J Endod · 2026-02-24

OBJECTIVE: To evaluate the long-term efficacy and safety of the bioceramic material iRoot BP Plus compared with mineral trioxide aggregate (MTA) in direct pulp capping for symptomatic irreversible pulpitis (SIP).…

要点

  • iRoot BP Plus与MTA直接盖髓36个月牙髓生存率无显著差异。
  • 术前疼痛VAS≥7是治疗失败的独立危险因素(HR=2.35)。

核心结论

  • iRoot BP Plus在症状性不可逆性牙髓炎直接盖髓中长期疗效与MTA相当,临床适用性和安全性良好。
  • 术前疼痛强度而非盖髓材料选择是预后的关键决定因素。

研究设计与样本

  • 采用有放回倾向性评分匹配平衡基线特征,iRoot BP Plus组与MTA组各92颗牙。
  • 主要结局为牙髓生存,采用临床和影像学联合标准评估。

主要发现

  • 绝对差异1.1%(95%CI:-8.4%至10.7%)。
  • 两组修复性牙本质桥形成率(78.3% vs. 75.0%)、活力反应和并发症率均无显著差异。

关键数值与推荐

  • 36个月牙髓生存率:iRoot BP Plus组88.0%(95%CI:79.6-93.4%),MTA组86.9%(95%CI:78.3-92.6%)。
  • 修复性牙本质桥形成率:iRoot BP Plus组78.3%,MTA组75.0%。

临床怎么用

  • iRoot BP Plus可作为MTA的替代材料用于SIP直接盖髓。
  • 术前应评估疼痛强度,VAS≥7者预后较差需加强随访。

局限性

  • 单中心回顾性设计。
  • 探索性多变量Cox回归采用精简协变量集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the long-term efficacy and safety of the bioceramic material iRoot BP Plus compared with mineral trioxide aggregate (MTA) in direct pulp capping for symptomatic irreversible pulpitis (SIP). METHODS: A single-center retrospective cohort study was conducted, including SIP patients who underwent direct pulp capping between January 2016 and December 2020, with a minimum follow-up of 36 months. Propensity score matching (PSM) with replacement was used to balance baseline characteristics, resulting in 92 teeth each in the iRoot BP Plus group and the MTA group The primary outcome was pulp survival, assessed by combined clinical and radiographic criteria. Statistical analyses for group comparisons incorporated weights from the PSM. Secondary outcomes included pain intensity changes, reparative dentin bridge formation, and complications. An exploratory multivariable Cox regression analysis with a reduced set of covariates was employed to identify prognostic factors, and sensitivity analyses were performed according to tooth position and preoperative pain level. RESULTS: At 36 months post-treatment, the pulp survival rate was 88.0% (95% confidence interval [CI]: 79.6-93.4%) in the iRoot BP Plus group and 86.9% (95% CI: 78.3-92.6%) in the MTA group, with no statistically significant difference (P = .730). The absolute difference was 1.1% (95% CI: -8.4% to 10.7%). No significant differences were observed between groups in reparative dentin bridge formation (78.3% vs. 75.0%), vitality response, or complication rates. Exploratory multivariate analysis identified higher preoperative pain level (visual analog scale ≥7) as an independent risk factor for treatment failure (hazard ratio = 2.35, 95% CI: 1.22-4.52, P = .010), whereas the type of capping material did not influence outcomes (hazard ratio = 0.98, 95% CI: 0.46-2.11, P = .962). Subgroup analyses further confirmed comparable performance of both materials across different tooth positions and pain strata. CONCLUSION: iRoot BP Plus demonstrates comparable long-term efficacy to MTA in direct pulp capping for SIP, with favorable clinical applicability and safety. Preoperative pain intensity, rather than the choice of capping material, appears to be a critical determinant of prognosis.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Lv H, Li Y, Cui H, et al. Long-term Survival and Outcomes of Direct Pulp Capping with Bioceramic iRoot BP Plus in Symptomatic Irreversible Pulpitis. J Endod. 2026. PMID: 41748067. doi:10.1016/j.joen.2026.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。